Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Tax Rate of 7.54% for Q1 2026, down 2409.0% year-over-year from 0.33% in Q1 2025, and up 109.9% quarter-over-quarter from 76.11% in Q4 2025.
Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Tax Rate history runs 10 years deep, the most recent figure standing at 7.54% for Q1 2026.
- In Q1 2026, Tax Rate fell 2409.0% year-over-year to 7.54%; the TTM figure through Mar 2026 stood at 28.99% (down 3287.0% YoY), while the FY2025 annual figure was 17.87%, down 2018.0% from the prior year.
- Tax Rate for Q1 2026 stood at 7.54%, up from 76.11% in the prior quarter.
- The five-year high for Tax Rate was 82.44% in Q2 2023, with the low at 76.11% in Q4 2025.
- The 5-year median for Tax Rate is 0.43% (2022), against an average of 1.01%.
- The sharpest annual moves came in 2023 and 2025: Tax Rate jumped 8376 bps in 2023, then plunged 7653 bps in 2025.
- Acadia Pharmaceuticals' Tax Rate stood at 1.96% in 2022, then plunged by 679 bps to 15.25% in 2023, then soared by 66 bps to 5.18% in 2024, then tumbled by 1370 bps to 76.11% in 2025, then jumped by 110 bps to 7.54% in 2026.
- Business Quant data shows ACAD's Tax Rate at 7.54% in Q1 2026, 76.11% in Q4 2025, and 60.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn | 32.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.26% |
| Jun 30, 2026 | 32.26% |
| Jun 30, 2026 | 32.26% |
| Mar 31, 2026 | 7.54% |
| Mar 31, 2026 | 7.54% |
| Mar 31, 2026 | 7.54% |
| Dec 31, 2025 | -76.11% |
| Dec 31, 2025 | -76.11% |
| Dec 31, 2025 | -76.11% |
| Sep 30, 2025 | -60.96% |
| Sep 30, 2025 | -60.96% |
| Sep 30, 2025 | -60.96% |
| Jun 30, 2025 | 33.69% |
| Jun 30, 2025 | 33.69% |
| Jun 30, 2025 | 33.69% |
| Mar 31, 2025 | 31.63% |
| Mar 31, 2025 | 31.63% |
| Mar 31, 2025 | 31.63% |
| Dec 31, 2024 | -5.18% |
| Dec 31, 2024 | -5.18% |